Protein Kinase C β (PRKCB1) and pigment epithelium derived factor (PEDF) gene polymorphisms and Diabetic Retinopathy in a south Indian cohort

Ophthalmic Genetics

Volumn 31, Issue 1, 2010, Pages 18-23

  Uthra, Satagopan ^a   Raman, Rajiv ^b   Mukesh, Bickol N ^c   Rajkumar, Samuel A ^a   Kumari R, Padmaja ^b   Lakshmipathy, Praveena ^a   Gnanamoorthy, Perumal ^b   Sharma, Tarun ^b   McCarty, Catherine A ^c   Kumaramanickavel, Govindasamy ^a  

^a VISION RESEARCH FOUNDATION   (India)

^b MEDICAL RESEARCH FOUNDATION   (India)

^c MARSHFIELD CLINIC   (United States)

Author keywords

Diabetic retinopathy; PEDF; PRKCB1; South India; Type 2 diabetes

Indexed keywords

GENOMIC DNA; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN KINASE C BETA;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DIABETIC RETINOPATHY; DNA POLYMORPHISM; EXON; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

AGED; ALLELES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EXONS; EYE PROTEINS; GENOTYPE; HUMANS; INDIA; MIDDLE AGED; NERVE GROWTH FACTORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; SERPINS;

EID: 76749153006     PISSN: 13816810     EISSN: 17445094     Source Type: Journal    
DOI: 10.3109/13816810903426231     Document Type: Article

References (22)

1. Uthra S, Raman R, Mukesh BN, et al. Intron 4 VNTR of endothelial nitric oxide synthase (eNOS) gene and diabetic retinopathy in type 2 patients in southern India. Ophthalmic Genet. 2007;28(2):77-81.
2. Uthra S, Raman R, Mukesh BN, et al. Diabetic retinopathy and IGF-1 gene polymorphic cytosine-adenine repeats in a southern Indian cohort. Ophthalmic Res. 2007;39(5): 294-299.
3. Uthra S, Raman R, Mukesh BN, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort. Ophthalmic Genet. 2008;29(1):11-15.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications Nature. 2001;414:813-820.
5. Kofler K, Erdel M, Utermann G, et al. Molecular genetics and structural genomics of the human protein kinase C gene module. Genome Biology. 2002;3(3):research0014.1- 0014.10.
6. Araki S, Ng DP, Krolewski B, et al. Identification of a common risk haplotype for diabetic nephropathy at the protein kinase C-beta1 (PRKCB1) gene locus. J Am Soc Nephrol. 2003;14(8):2015-2024.
7. Araki S, Haneda M, Sugimoto T, et al. Polymorphisms of the protein kinase C-beta gene (PRKCB1) accelerate kidney disease in type 2 diabetes without overt proteinuria. Diabetes Care. 2006;29(4):864-868.
8. Liu H, Ren JG, Cooper WL, et al. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site. Proc Natl Acad Sci USA 2004, 27;101(17):6605-6610.
9. Ogata N, Tombran-Tink J, Nishikawa M, et al. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am J Ophthalmol. 2001;132(3):378-382.
10. Holekamp NM, Bouck N, Volpert O. Pigment epithelium- derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol. 2002;134(2):220-227.
11. Ogata N, Nishikawa M, Nishimura T, et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol. 2002;134(3):348-353.
12. Bilak MM, Becerra SP, Vincent AM, et al. Identification of the neuroprotective molecular region of pigment epithelium- derived factor and its binding sites on motor neurons. J Neurosci. 2002;22(21):9378-9386.
13. Rani PK, Raman R, Agarwal S, et al. Diabetic retinopathy screening model for rural population: awareness and screening methodology. Rural Remote Health. 2005;5(4):350, epub Oct 10.
14. Agarwal S, Raman R, Paul PG, et al. Sankara Nethralaya- Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): Study design and research methodology. Ophthalmic Epidemiol. 2005;12(2):143-153.
15. Klein R, Klein BEK, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 1986;93: 1183-1187.
16. World Medical Organization. Declaration of Helsinki. Br Med J. 1996;313(7070): 1448-1449.
17. Wolff R, Gemmil R. Purifying and analyzing genomic DNA. Bruce B, Green ED, Hieter P, Klaplholz S, Meyers RM, Riethman H, Roskans J, (eds): Genome Analysis A Laboratory Manual. Vol 4. New York. Cold Spring Harbor Laboratory Press (1998); pp. 1-82.
18. Koenekoop R, Pina AL, Loyer M, et al. Four polymorphic variations in the PEDF gene identified during the mutation screening of patients with Leber congenital amaurosis. Mol Vis. 1999; 2:5-10.
19. Ono Y, Kikkawa U, Ogita K, et al. Expression and properties of two types of protein kinase C: Alternative splicing from a single gene. Science. 236;1987:1116-1120.
20. Yamagishi S, Amano S, Inagaki Y, et al. Pigment epithelium- derived factor Met72Thr polymorphism in patients with diabetic microangiopathy. Int J Clin Pharmacol Res. 2002;22(3-4):67-71.
21. Kimchi-Sarfaty C, Oh JM, Kim IW, et al.A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007,315(5811):525-528. (Pubitemid 46175758)
22. Nakamura Y, Gojobori T, Ikemura T. Codon usage tabulated from the international DNA sequence databases: status for the year 2000. Nucl. Acids Res. 2000;28:292.